@FiercePharma: India eases path for small companies to bid in medical product tenders. FiercePharmaAsia article | Follow @FiercePharma
@EricPFierce: ICYMI: Novo putting $225M into new plant in Denmark for hemophilia treatments. Report | Follow @EricPFierce
@CarlyHFierce: Big new launches rocket cancer drug spending to $100B: IMS report. More | Follow @CarlyHFierce
> Teva ($TEVA) has filed an updated investor presentation reiterating its $82-per-share Mylan ($MYL) buyout proposal. Release
> Giovanni Caforio has assumed the post of CEO at Bristol-Myers Squibb ($BMY). Report
> China will remove price caps for most therapies from June 1, and giving the market a larger role in setting prices in the country. More
> The Supreme Court has brought Bristol-Myers Squibb's hopes of reviving patent protection for its Baraclude hep B treatment to an end, declining to hear its challenge to an appeals court ruling in favor of copycat drugmaker Teva. Report
> Teva has closed its $3.2 billion acquisition of Auspex Pharmaceuticals. Report
> Mallinckrodt ($MNK) said its profit leapt in its latest quarter, and it lifted its outlook for the year after recent pickup Ikaria helped boost sales. Report
Medical Device News
@FierceMedDev: Myriad Genetics stumbles as rivals flood BRCA market. FierceDiagnostics story | Follow @FierceMedDev
@EmilyWFierce: Scientists harness new technology for artificial knee implants. Report | Follow @EmilyWFierce
> Open-source software released to connect Apple ResearchKit to the cloud for use in clinical trials. News
> Researchers question safety of off-label device use in atrial fibrillation, call for 510(k) review process. Report
Biotech News
@FierceBiotech: ICYMI yesterday: Bayer fronting $155M for a promising anticoagulant from Isis Pharma. Report | Follow @FierceBiotech
@JohnCFierce: The drumbeat of bad news at $GSK should lead to a change of CEOs. Breaking up the co. will be the focus as well. More from Bloomberg | Follow @JohnCFierce
> Tobira pulls off a $40M Wall Street end-around with sights set on NASH. More
> Roche presses pause on PTC's SMA drug over a safety scare. Article
> Corbus who? A tiny biotech is shoved into the rink with a hulking Vertex. Story
> GlaxoSmithKline files for gene therapy OK as a case of the jitters sets in. Report
Pharma Manufacturing News
> Zoetis to whack 10 plants as part of cost-cutting scheme. News
> U.K. regulators find issues with Indian-owned API distributor Relonchem. More
> WuXi starts work in China on yet another cell-line manufacturing facility. Article
> Recro Pharma and Alkermes close deal on DEA-approved plant in Georgia. Story
> Novo building $225M plant for hemophilia treatments. Report
Pharma Asia News
> China's SAIC denies probe as reports proliferate on alleged devices crackdown. Article
> India eases path for small companies to bid in medical product tenders. Story
> China plans first-ever rules on animal testing in medical research by year end. More
> Otsuka device unit works with UniCare on urinary bladder products. Report
> Japan to adopt CDISC clinical data standards from October 2016. Item
Drug Delivery News
> NIH says viral vector for delivering gene therapy to treat blindness shows promise, Wall Street less sure. More
> UNC scientists bypass blood-brain barrier with exosomes to treat Parkinson's. Report
> Northwestern team puts spherical RNA in common skin moisturizer to speed up wound healing. Story
> Medicines Co. gets FDA approval of first patient-controlled patch for postoperative pain. Item
> Deerfield Management buys 8% stake in manufacturer of custom hydrogels and wound dressings. Article
And Finally... A drug derived from Caribbean reefs may treat psoriasis and multiple sclerosis. Story